Biosel Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Biosel Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Real Estate Property Managers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Outpatient Care Centers

Full name: Biosel Sp. z o.o.

Profile Updated: April 24, 2024

Biosel Sp. z o.o. is based in Poland. The head office is in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on June 01, 2009. The total number of employees is currently 5 (2015). Over the same period, its total assets decreased by 3.71%.

Headquarters
Ul. Janusza Meissnera 2/36
Warsaw; Mazowieckie; Postal Code: 03-982

Contact Details: Purchase the Biosel Sp. z o.o. report to view the information.

Website: http://www.selol.pl

Basic Information

Total Employees:

Purchase the Biosel Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Biosel Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Biosel Sp. z o.o. report to view the information.

Incorporation Date:

June 01, 2009

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

96%

Company Performance

Financial values in the chart are available after Biosel Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Total operating revenue

14079.17%▲

Operating profit (EBIT)

N/A

Net Profit (Loss) for the Period

N/A

Total assets

-3.71%▼

Total equity

7.33%▲

Return on Equity (ROE)

N/A

Quick Ratio

1.95%▲

Cash Ratio

0.03%▲

Similar companies